BBIO
NASDAQ · Biotechnology
Bridgebio Pharma Inc
$68.53
-1.07 (-1.54%)
Performance
1D
—
1W
—
1M
—
3M
-9.59%
6M
+36.92%
1Y
+86.53%
YTD
-12.40%
Open$68.87
Previous Close$69.60
Day High$69.28
Day Low$67.57
52W High$84.94
52W Low$28.33
Volume—
Avg Volume2.32M
Market Cap13.58B
P/E Ratio—
EPS$-3.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.38
Below
SMA 200
$56.39
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
+177.3% upside
Current
$68.53
$68.53
Target
$190.06
$190.06
$141.92
$190.06 avg
$243.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 519.54M | 278.87M | 2.34B |
| Net Income | -750,150,718 | -362,391,651 | -436,239,166 |
| Profit Margin | -144.4% | -137.2% | -18.6% |
| EBITDA | -513,332,992 | -261,764,005 | -548,703,476 |
| Free Cash Flow | — | — | -421,297,535 |
| Rev Growth | +86.3% | +86.3% | -0.2% |
| Debt/Equity | 8.27 | 8.27 | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |